Low-dose Azacitidine and Venetoclax Maintenance Following Allogeneic Hematopoietic Stem Cell Transplantation in High-risk AML and MDS Patients: Single Center Retrospective Analysis

Date

2022

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Citation

Edgar, C. M., Clark, P., Patel, R. D., Varela, J. C., & Mori, S. (2022). Low-dose azacitidine and venetoclax maintenance following allogeneic hematopoietic stem cell transplantation in high-risk AML and MDS patients: Single center retrospective analysis. Transplantation and Cellular Therapy, 28(3), S434. https://doi.org/10.1016/S2666-6367(22)00717-5

URI

https://doi.org/10.1016/S2666-6367(22)00717-5
 https://hdl.handle.net/20.500.12521/482

DOI

Collections

Physician Assistant: Peer-Reviewed Resources Other Than Journal Articles